The latest projections of the COVID-19 pandemic in Canada suggest a glimmer of hope, but federal officials warn more work still needs to be done to beat the third wave.
National Online Journalist
Previously, NACI recommended that these groups be offered COVID-19 vaccines in ‘some circumstances, and on a case-by-case basis,’ if the benefits outweighed the risks.
Countries around the world have been trying to figure out the right balance for years, and COVID-19 has pushed Canada to think harder.
Experts say there is value in having a roadmap to reopening from tight COVID-19 restrictions, but Canadians need to recognize it still may change.
That uncertainty has led the government to revise projections — perhaps temporarily — on how many COVID-19 vaccine doses will be in Canada by the end of June.
Given the progress on COVID-19 vaccine coverage in both countries, one U.S. lawmaker believes it’s time to rethink the current rules at the border.
With the vast majority of Canada’s COVID-19 related deaths still stemming from the elderly age group, some experts say value in readjusting the second-dose interval.
Experts say a new study highlights the dangers associated with working long hours, and that change needs to come at a policy level.
As of this week, more than 50 per cent of eligible Canadians have received their first dose of a COVID-19 vaccine, officials said.
While access and eligibility remain barriers in Canada, vaccine hesitancy has started to hamper efforts in the United States. To combat it, some businessess are getting creative.
The dispute first erupted last November, when Michigan Gov. Gretchen Whitmer gave Enbridge until May 12, 2021 to cease operations. The company has so far been defiant.
Alberta says the decision was made due to obscurity over future AstraZeneca COVID-19 vaccine supply, not safety. Some experts say this strategy makes sense — for now.
Experts say Canada could see trickle-down effects of the Colonial Pipeline hack — whether through gas prices or more symbolic implications, like its own infrastructure’s security.
Trudeau emphasized that Canada is not ‘blocking or interfering’ in the process over COVID-19 vaccine patent waivers with the WTO
The U.S. and EU support is a ‘signal that IP rights can legitimately be limited’ during a health crisis like COVID-19, one expert said.